ARCHIVES

Control-Arm CML Patients In Phase III Gleevec Study Allowed To Switch.

This article is from The Cancer Letter archive.

Vol. 28 No. 04 | January 25, 2002

Download PDF Visit The Full Archive

Related Articles

FDA Staff Failed To Explain Approval Standards, Correct Misconceptions.

April 13, 2007

Centers, Groups, Others May Land in DeVita’s Office; Hammer Offers Deal congress Can’t Refuse

February 5, 1988

Senate confirms Crawford as FDA commissioner.

July 22, 2005

CTEP-Approved Trials For the Month of June

June 28, 2013

In Brief: Carnegie Mellon President Emeritus honored By UPCI; Schiffer Leaves Maryland for Detroit

October 17, 1997

I-ELCAP Moves From Weill Cornell To Arizona State; PIs Move To Mount Sinai.

January 22, 2010